SEARCH

SEARCH BY CITATION

References

  • 1
    Krieger JN. Trichomoniasis in men: old issues and new data. Sex Transm Dis 1995; 22: 8396.
  • 2
    Krieger JN,Alderete JF. Trichomonas vaginalis and trichomoniasis. In: HolmesK,SparlingP,MardhP,LemonS,StammW,PiotP,WasserheitJ, eds. Sexually transmitted diseases,3rd edn. New York: The McGraw-Hill Companies Inc., 1999. 587604.
  • 3
    Sutcliffe S,Giovannucci E,Alderete JF,Chang TH,Gaydos CA,Zenilman JM,De Marzo AM,Willett WC,Platz EA. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 93945.
  • 4
    Weston TET,Nicol CS. Natural history of trichomonal infection in males. Br J Vener Dis 1963; 39: 2517.
  • 5
    Coutts WE,Silva-Inzunza E,Tallman B. Genito-urinary complications of non-gonococcal urethritis and trichomoniasis in males. Urol Int 1959; 9: 189208.
  • 6
    Drummond A. Trichomonas infestation of the prostate gland. Am J Surg 1936; 31: 98103.
  • 7
    Watt L,Jennison RF. Incidence of Trichomonas vaginalis in marital partners. Br J Vener Dis 1960; 36: 1636.
  • 8
    Allen E,Jensen LB,Wood IH. Clinical and bacteriologic observations in Trichomonas vaginitis. Am J Obstet Gynecol 1935; 30: 56570.
  • 9
    Gardner WA,Jr,Culberson DE,Bennett BD. Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 1986; 110: 4302.
  • 10
    Smith CJ,Gardner WA,Jr. Inflammation-proliferation: possible relationships in the prostate. In: CoffeyDS,GardnerWA,Jr,BruchovskyN,ResnickMI,KarrJP, eds. Current concepts and approaches to the study of prostate cancer, vol. 239. New York: Alan R Liss, 1987. 31725.
  • 11
    Guenthner PC,Secor WE,Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun 2005; 73: 415560.
  • 12
    Rendon-Maldonado JG,Espinosa-Cantellano M,Gonzalez-Robles A,Martinez-Palomo A. Trichomonas vaginalis: in vitro phagocytosis of lactobacilli, vaginal epithelial cells, leukocytes, and erythrocytes. Exp Parasitol 1998; 89: 24150.
  • 13
    Gilbert RO,Elia G,Beach DH,Klaessig S,Singh BN. Cytopathogenic effect of Trichomonas vaginalis on human vaginal epithelial cells cultured in vitro. Infect Immun 2000; 68: 42006.
  • 14
    Kucknoor A,Mundodi V,Alderete JF. Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol 2005; 7: 88797.
  • 15
    Goodman PJ,Tangen CM,Crowley JJ,Carlin SM,Ryan A,Coltman CA,Jr,Ford LG,Thompson IM. Implementation of the Prostate Cancer Prevention Trial (PCPT). Control Clin Trials 2004; 25: 20322.
  • 16
    Kristal AR,Arnold KB,Schenk JM,Neuhouser ML,Goodman P,Penson DF,Thompson IM. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Am J Epidemiol 2008; 167: 92534.
  • 17
    Sutcliffe S,Platz EA. Inflammation and prostate cancer: a focus on infections. Curr Urol Rep 2008; 9: 2439.